Related Experiment Videos
Pulmonary vasoconstriction induced by mitral valve obstruction in sheep
C I Hermo-Weiler1, T Koizumi, R Parker
1Vanderbilt Center for Lung Research, Nashville 37232, Tennessee, USA.
Journal of Applied Physiology (Bethesda, Md. : 1985)
|November 6, 1998
Summary
Left atrial hypertension causes pulmonary vasoconstriction, a response not fully revealed by standard measurements. This study quantifies this effect and its location in the pulmonary circulation.
Area of Science:
- Cardiovascular Physiology
- Pulmonary Circulation Research
Background:
- Left atrial hypertension is often associated with pulmonary hypertension.
- Pulmonary vascular resistance is expected to decrease passively with elevated left atrial pressure.
Purpose of the Study:
- To demonstrate and quantify pulmonary vasoconstriction during experimental left atrial hypertension.
- To identify the location of this vasoconstriction within the pulmonary circulation.
- To investigate the underlying mechanism of this reactive vasoconstriction.
Main Methods:
- Utilized instrumented sheep to measure pulmonary arterial (Ppa), left atrial (Pla), and systemic arterial pressures (Psa).
- Employed a Foley balloon catheter to induce controlled left atrial hypertension and a Swan-Ganz catheter for distal pulmonary arterial wedge pressure (Ppaw).
- Calculated total, upstream, and downstream pulmonary vascular resistances (PVR) and assessed responses to nitric oxide, phentolamine, atropine, and ibuprofen.
Main Results:
- Left atrial hypertension led to an elevation in pulmonary arterial pressure (Ppa) with minimal change in cardiac output (CO).
- Nitric oxide inhalation significantly reduced PVR, with a more pronounced effect at higher left atrial pressures.
- The vasodilator effect of nitric oxide was most significant in the downstream pulmonary vessels.
Conclusions:
- Experimental left atrial hypertension induces reactive pulmonary vasoconstriction, particularly in downstream vessels.
- The mechanism of this vasoconstriction remains unclear, as tested pharmacological agents did not elucidate it.
- Further research is needed to fully understand the reactive pulmonary vasoconstriction in response to left atrial hypertension.